Repros Therapeutics (RPRX) Prices 3.5M Shares at $1.27/Share
Repros Therapeutics (Nasdaq: RPRX) today announced that Repros has entered into a definitive agreement with institutional investors to sell 3.5 million shares of its common stock at $1.27 per share for gross proceeds of approximately $4.4 million. The offering is expected to close on or about October 9, 2009, subject to the satisfaction of customary closing conditions.
You May Also Be Interested In
- Notable 52-Week Highs and Lows of the Day 05/25: (LCC) (RPRX) High; (DCTH) (MXWL) (VIP) Low
- Delcath Systems (DCTH) Announces Common, Warrants Offering
- New York Mortgage Trust (NYMT) Announces 4M Common Offering
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
